Advertisement

Krebsvorsorge und Füherkennung

  • Heinz-Harald Abholz
Chapter

Zusammenfassung

Früherkennungsuntersuchungen auf Mamma-Karzinome bei Frauen gehören in Deutschland zu den gesetzlich verankerten und von der Krankenversicherung getragenen Maßnahmen. Dies bezieht sich auf die körperliche Untersuchung und bei Verdacht auf ein Karzinom oder bei Frauen aus Risikogruppen auch auf die Mammographie. Der Nutzen für die einzelne Frau ist allerdings nach wie vor nicht unumstritten als positiv zu beurteilen. Allerdings kann sowohl der individuelle als auch der Public-Health-Nutzen durch verschiedene Maßnahmen deutlich erhöht werden. Hierzu zählt beispielsweise die Doppelbefundung von Mammographien sowie die Befundung durch einen in diesem Bereich sehr erfahrenen Arzt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Abholz, H.-H.: Rationalitäten in der Medizin. Jahrbuch für Kritische Medizin 22, 1994: 79–95 Google Scholar
  2. [2]
    Alexander, F. E., Anderson, T. J., Brown, H. K. et al: 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. The Lancet, 1999, 353: 1903–08 CrossRefGoogle Scholar
  3. [3]
    Andersson, I., Janzon, L.: Reduced Breast Cancer Mortality in Women under Age 50: Updated Results From the Malmö Mammographic Screening Program. Monogr Natl Cancer Inst, 1997, 22: 63–67 PubMedGoogle Scholar
  4. [4]
    Barrait, A., Cockburn, J., Furnival, C. et al: Perceived sensitivity of mammographic screening: women’s views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health, 1999, 53: 716–20 CrossRefGoogle Scholar
  5. [5]
    Barton, M. B., Harris, R., Fletcher, S. W.: Does This Patient Have Breast Cancer? AMA, 1999, 282: 1270–80 Google Scholar
  6. [6]
    Beemsterboer, P. M. M., Warmerdam, P. G., Boer, R. et al: Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J. Med. Screen, 1998, 5: 81–87 PubMedCrossRefGoogle Scholar
  7. [7]
    Chalmers, T.C.: Mammography — 30 years after. Online J. Curr. Clin. Trials, 1993, Doc No 66 Google Scholar
  8. [8]
    Clark, R. A.: Breast Cancer. Cancer Screening St. Louis, Missouri, Mosby-Year Book, 1996:23–40 Google Scholar
  9. [9]
    Dokumentation der 1. Expertentagung in Frankfurt am 2. November 1993: Qualitätssicherung in der Mammographie Google Scholar
  10. [10]
    Elske van der Akker, M., de Koning, H., Boer, R. et al: Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands comparison with the United Kingdom. J. Med. Screen, 1999, 6: 30–34 CrossRefGoogle Scholar
  11. [11]
    Europe against cancer: European Guidelines for quality assurance in mammography screening. Commission of the European Communities, Brüssel 1993 Google Scholar
  12. [12]
    Feig, S.A.: Routine Mammographic Screening: Does it Reduce Mortality? in: Breast Cancer: Controversies in Management, New York, Futura Publishing Company, Inc, 1994: 305–25 Google Scholar
  13. [13]
    Ferguson, J. H.: National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40–49. J Natl Cancer Inst, 1997, 89:1015–26 CrossRefGoogle Scholar
  14. [14]
    Fitzgibbons, P. L., Henson, D. E., Hutter, R. V. P. et al: Benign Breast Changes and the Risk for Subsequent Breast Cancer. Arch Pathol Lab Med, 1998, 122:1053–55 PubMedGoogle Scholar
  15. [15]
    Franceschi, S., Levi, F., La Vecchia, C. et al: Second cancers following in situ carcinoma of the breast. Int. J. Cancer, 1998, 77: 392–95 PubMedCrossRefGoogle Scholar
  16. [16]
    Frischbier, H.-J., Hoeffken, W., Robra, B.-P.: Mammographie in der Krebsfrüherkennung. Stuttgart, Enke Verlag, 1994 Google Scholar
  17. [17]
    Gøtzsche, P. C., Olsen, O.: Is screening for breast cancer with mammography justifiable? The Lancet, 2000, 355: 129–34 CrossRefGoogle Scholar
  18. [18]
    Hakama, M., Pukkala, E., Söderman, B. et al: Implementation of screening as a public health policy: issues in design and evaluation. J. Med. Screen., 1996, 6:209–16 CrossRefGoogle Scholar
  19. [19]
    Harris, R., Leininger, L.: Clinical strategies for Breast Cancer Screening: Weighing and Using the Evidence. Ann Intern Med, 1995, 122: 539–47 PubMedCrossRefGoogle Scholar
  20. [20]
    Hill, D., White, V., Jolley, D. et al: Self examination of the breast: Is this beneficial? Meta-analysis of studies investigating breast self examination and extent of disease in patients with breast cancer. BMJ, 1988, 297: 271–75 PubMedCrossRefGoogle Scholar
  21. [21]
    Holmberg, L., Ekbom, A., Calle, E. et al: Breast cancer mortality in relation to self-reported use of breast self-examination: a cohort study of 450.000 women. Breast Cancer Res. Treat, 1997, 43:137–40 PubMedCrossRefGoogle Scholar
  22. [22]
    Hurley, S. F., Kaldor, J. M.: The benefits and risks of mammographic screening for breast cancer. Epidemiol. Rev., 1992, 14: 101–30 PubMedGoogle Scholar
  23. [23]
    Jatoi, I., Baum, M.: American and European recommendations for screening mammography. Brit. Med. J. 1993, 307: 1481–83 PubMedCrossRefGoogle Scholar
  24. [24]
    Knox, E.G.: Evaluation of a proposed cancer screening. Brit. Med. J. 1988, 297: 650–54 PubMedCrossRefGoogle Scholar
  25. [25]
    Kopans, D. B.: Breast-cancer screening with ultrasonography. The Lancet, 1999, 354: 2096–97 CrossRefGoogle Scholar
  26. [26]
    Letters: »Screening mammography reevaluated«. The Lancet, 2000, 355: 747–53 Google Scholar
  27. [27]
    Libstug, A. R., Moravan, V., Aitken, S. E.: Results from the Ontario breast screening program, 1990–1995. J. Med. Screen., 1998, 5:73–80 PubMedCrossRefGoogle Scholar
  28. [28]
    Muhlhauser, I., Höldke, B.: Mammogra-phie-Screening — Darstellung der wissenschaftlichen Evidence-Grundlage zur Kommunikation mit der Frau. Arznei-Telegramm, 1999:101–08 Google Scholar
  29. [29]
    Mueller, C. B.: The Natural History of Breast Cancer, in: Breast Cancer: Controversies in Management, New York, Futura Publishing Company, Inc, 1994:29–39 Google Scholar
  30. [30]
    O’Malley, M. S., Fletcher, S. W., Morrison, B.: Does screening for Breast Cancer Save Lifes? in: Preventing Disease, Beyond the Rhetoric, New York, Springer Verlag, 1990:251–64 Google Scholar
  31. [31]
    Rembold, Ch. M.: Number needed to screen: development of a statistic for disease screening. Brit. Med. J., 1998, 317:307–12 PubMedCrossRefGoogle Scholar
  32. [32]
    Rodes, N. D., et al: The impact of breast cancer screening on survival. Cancer, 1986, 57: 223–26 CrossRefGoogle Scholar
  33. [33]
    Sautter-Bihl, M.-L., Bamberg, M.: Das Mammakarzinom: Systemerkrankung oder lokales Problem? Deutsches Ärzteblatt, 2000, 97, 1–2:38–44 Google Scholar
  34. [34]
    Schmidt, J.G.: The epidemiology of mass breast cancer screening — a plea for a valid measure of benefit. J. Clin. Epidemiol., 1990, 43: 215–27 PubMedCrossRefGoogle Scholar
  35. [35]
    Schouten, L. J., Marjan de Rijke, J., Schlangen, J. T. et al: Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands. J. Med. Screen., 1998, 5:37–41 PubMedCrossRefGoogle Scholar
  36. [36]
    Silverstein, M. J.: Ductal carcinoma in situ of the breast. Brit. Med. J., 1998, 317: 734–39 PubMedCrossRefGoogle Scholar
  37. [37]
    Sox, H. C.: Screening Mammography in Women Younger than 50 Years of Age. Ann Intern Med, 1995, 122: 550–52 PubMedCrossRefGoogle Scholar
  38. [38]
    Thomas, D. B., Li Gao, Dao, Self, S. G. et al: Randomized Trial of Breast Self-examination in Shanghai: Methodology and Preliminary Results, Journal of National Cancer Institute, 1997, 89, 5:355–65 CrossRefGoogle Scholar
  39. [39]
    UK Trial of Early Detection of Breast Cancer group: 16-year mortality from breast cancer in the UK. Trial of Early Detection of Breast Cancer. The Lancet, 1999, 353: 1909–14 CrossRefGoogle Scholar
  40. [40]
    Wärnberg, F., Yuen, J., Holmberg, L.: Risk of subsequent invasive breast cancer after breast carcinoma in situ. The Lancet, 2000, 355: 724–25 CrossRefGoogle Scholar
  41. [41]
    Waterhouse, J. A. H.: Cancer Handbook of Epidemiology and Prognosis. New York, Longman Group Limited, 1974 Google Scholar
  42. [42]
    Wilson, J. M. G., Jungner, G.: Principles and practice of screening for disease. WHO, Genf 1968 Google Scholar
  43. [43]
    Wohlfahrt, J., Andersen, P. K., Mouridsen, H. T., et al: Reproductive History and Stage of Breast Cancer. Am J Epidemiol, 1999, 150:1325–30 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • Heinz-Harald Abholz

There are no affiliations available

Personalised recommendations